Sandbox WWC1: Difference between revisions

From Proteopedia
Jump to navigationJump to search
No edit summary
No edit summary
Line 15: Line 15:
94. </ref> <ref> Minton NP. 1995. Molecular genetics of
94. </ref> <ref> Minton NP. 1995. Molecular genetics of
clostridial neurotoxins. Curr. Top. Microbiol.
clostridial neurotoxins. Curr. Top. Microbiol.
Immunol. 195:161–94 </ref> <ref> Oguma K, Fujinaga Y, Inoue K. 1995.Structure and function of Clostridium botulinum toxins. Microbiol. Immunol. 39:161–68 </ref> <ref name="Lacy"> PMID: 3722863 </ref> <ref>  Popoff MR, Marvaud J-C. 1999. Structural and genomic features of clostridial neurotoxins. See Ref. 132, pp. 174–
Immunol. 195:161–94 </ref> <ref> Oguma K, Fujinaga Y, Inoue K. 1995.Structure and function of Clostridium botulinum toxins. Microbiol. Immunol. 39:161–68 </ref> <ref name="Lacy"> PMID: 3722863</ref> <ref>  Popoff MR, Marvaud J-C. 1999. Structural and genomic features of clostridial neurotoxins. See Ref. 132, pp. 174–
201 </ref>).  
201 </ref>).  


Line 24: Line 24:
== Function ==
== Function ==


The active form of BTX has three functional domains responsible for binding, translocation, and catalysis <ref>Montecucco and Schiavo 1995 C. Montecucco, G. Schiavo Structure and function of tetanus and botulinum neurotoxins Quart. Rev. Biophys., 28 (1995), pp. 423–472. </ref>. The C terminus of the heavy chain is responsible for binding a ganglioside and protein receptors on the nerve terminal while the N terminus half functions by translocating the protein across the membrane by signaling endocytosis <ref>Dolly et al 1984 J.O. Dolly, J. Black, R.S. Williams, J. Melling Acceptors for botulinum neurotoxin reside on motor nerve terminals and mediate its internalization Nature, 307 (1984), pp. 457–460 </ref>. Once in a vesicle in the cytosol of a nerve terminal, the light chain dissociates from the heavy chain and cleaves SNARE proteins involved in synaptic vesicle fusion. The cleavage of these SNARE proteins, VAMP, SNAP-25, and syntax, depends on the serotype of BTX where each serotype cuts at a different place. The cut SNAREs inhibit the binding of vesicles containing acetylcholine which effectively stops the signaling from nerves to muscle cells, resulting in paralysis <ref>Lacy, D. B.; Stevens, R. C. Sequence Homology and Structural Analysis of the Clostridial neurotoxins1. J. Mol. Biol. 1999, 291 (5), 1091–1104.
The active form of BTX has three functional domains responsible for binding, translocation, and catalysis <ref>Montecucco and Schiavo 1995 C. Montecucco, G. Schiavo Structure and function of tetanus and botulinum neurotoxins Quart. Rev. Biophys., 28 (1995), pp. 423–472. </ref>. The C terminus of the heavy chain is responsible for binding a ganglioside and protein receptors on the nerve terminal while the N terminus half functions by translocating the protein across the membrane by signaling endocytosis <ref>Dolly et al 1984 J.O. Dolly, J. Black, R.S. Williams, J. Melling Acceptors for botulinum neurotoxin reside on motor nerve terminals and mediate its internalization Nature, 307 (1984), pp. 457–460 </ref>. Once in a vesicle in the cytosol of a nerve terminal, the light chain dissociates from the heavy chain and cleaves SNARE proteins involved in synaptic vesicle fusion. The cleavage of these SNARE proteins, VAMP, SNAP-25, and syntax, depends on the serotype of BTX where each serotype cuts at a different place. The cut SNAREs inhibit the binding of vesicles containing acetylcholine which effectively stops the signaling from nerves to muscle cells, resulting in paralysis <ref name="Lacy" />
</ref>.  
</ref>.  
== Disease ==
== Disease ==